Previous 10 | Next 10 |
2023-10-11 12:51:59 ET Shares of several major dialysis stocks plunged on Wednesday after Novo Nordisk (NYSE: NVO) indicated one of its diabetes treatments could also be used to treat chronic kidney disease. Dialysis products and services providers were broadly negative in early...
2023-10-11 11:15:44 ET More on Eli Lilly, Novo Nordisk, etc. Eli Lilly: Do Not Chase This Stock Over The Cliff Eli Lilly: Big Cancer Bet With Point Biopharma Global Purchase Eli Lilly POINTs Toward Radiopharmaceutical Ambitions Biggest stock movers today: Pio...
2023-10-11 10:03:52 ET More on DaVita DaVita: Continued Economic Hurdles, Market Expectations May Be Correct DaVita Inc. (DVA) Q2 2023 Earnings Call Transcript DaVita: Breakout Not Supported Without Leverage Effects, Reiterate Hold Dialysis stocks tumble in w...
2023-10-11 09:37:37 ET Stock markets looked poised to continue their winning ways on Wednesday morning, as stock index futures were higher across the board. Investors will get a look today at the latest thought process from the Federal Reserve when it releases the minutes of its most recent...
2023-10-11 09:24:05 ET More on Baxter, DaVita, etc. Outset Medical Faces Regulatory Delays Amid Heavy Cash Burn (Rating Downgrade) DaVita: Continued Economic Hurdles, Market Expectations May Be Correct Dividend Challengers Review: Baxter International DaVita ...
2023-10-11 08:28:56 ET More on Baxter, Denison Mines, etc. Denison Mines: Top Projects, Robust Balance Sheet, And Deeply Undervalued Denison Mines: A Promising Uranium Exploration Company Denison Mines: The Feasibility Study Demonstrates Wheeler's Potential D...
2023-10-11 06:53:54 ET Summary Birkenstock prices IPO at $46 per share, raising close to $1.5B and valuing the company at just under $9B. The Biden administration is set to announce up to $7B in funds for hydrogen hubs in the US. Samsung Electronics expects a decline in Q3 ope...
2023-10-11 05:57:33 ET Related stories E2open Parent Holdings, Inc. (ETWO) Q2 2024 Earnings Call Transcript E2open Parent Holdings: Still Running House Money But Q2 Was Rough DaVita: Continued Economic Hurdles, Market Expectations May Be Correct Novo Nordisk ...
2023-10-10 18:07:12 ET More on DaVita DaVita: Continued Economic Hurdles, Market Expectations May Be Correct DaVita Inc. (DVA) Q2 2023 Earnings Call Transcript DaVita: Breakout Not Supported Without Leverage Effects, Reiterate Hold DaVita raised to Buy at UBS...
2023-10-04 21:46:29 ET Summary DaVita Inc. stock has been heavily sold in '23, trading below its 50-day moving average for the past 8 weeks. The company lacks economic value, and its reinvestment runway looks limited, producing sub-standard returns on capital. The market expec...
News, Short Squeeze, Breakout and More Instantly...
DaVita Inc. Schedules 2nd Quarter 2024 Investor Conference Call PR Newswire DENVER , July 18, 2024 /PRNewswire/ -- DaVita Inc. (NYSE: DVA), announced today that it will hold its quarterly conference call to discuss second quarter results on Tuesday, Aug...
2024-06-21 02:20:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...